Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05632744

Evaluation of CG-100 Intraluminal Bypass Device

Conditions: Colorectal Cancer

Sex: All

Ages: 22 Years – 75 Years

Phase: NA

Enrollment: 10

Sponsor: Colospan Ltd.

Summary

Evaluation of CG-100 Intraluminal Bypass device

Eligibility Criteria

Inclusion Criteria (pre-operative):Willing to comply with protocol-specified follow-up evaluations22-75 (inclusive) years of age at screeningDiagnosed with colorectal cancerHas been informed of the nature of the study, agrees to its provisions, and has provided written informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05632744). StuddyBuddy aggregates publicly available trial information.